Form Type: 4

SEC EDGAR Link
Accession Number:0001179110-22-002932
Date:2022-05-06
Issuer: ABBVIE INC. (ABBV)
Original Submission Date:

Reporting Person:

TILTON GLENN F
1 N. WAUKEGAN ROAD
NORTH CHICAGO, IL 60064

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, $0.01 PAR VALUE 2022-05-06 A 1,421 a $0.00 47,589 direct
COMMON STOCK, $0.01 PAR VALUE 2022-05-06 0 $0.00 350 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 these are restricted stock units awarded under the abbvie amended and restated 2013 incentive stock program (the "program"). they will be paid, on a one-to-one basis, in shares of abbvie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the program).
f2 the reporting person disclaims beneficial ownership of all securities held by his wife.
WhaleWisdom Logo

Elevate your investments